Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

APRICOT: Anaesthesia PRactice In Children Observational Trial (APRICOT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01878760
Recruitment Status : Completed
First Posted : June 17, 2013
Last Update Posted : October 14, 2015
Sponsor:
Information provided by (Responsible Party):
European Society of Anaesthesiology

Brief Summary:

The aims of the APRICOT study are:

  • To establish the incidence of severe critical events in children undergoing anesthesia in Europe.
  • To describe the differences in paediatric anaesthesia practice throughout Europe.
  • To study the potential impact of this variability on the occurrence of severe critical events (Laryngospasm, Bronchospasm, Pulmonary aspiration, Drug error, Anaphylaxis, Cardiovascular instability, Neurological damage, Perianaesthetic cardiac arrest and postanaesthetic Stridor).

Condition or disease
Anaesthesia Children

Detailed Description:

Despite the introduction of better-structured programmes for paediatric anaesthesia training and the development of some recommendations for paediatric anaesthesia services, the incidence of severe critical events in children is still unknown in Europe. Considering that the major life-threatening complications following general or regional anaesthesia are uncommon, it is therefore crucial to consider a large multinational, multicentre trial in order to establish a realistic statistical estimation and identify the risk factors for severe critical events. Thus, this prospective observational multicentre cohort study is designed to identify the incidence and potential risk factors of severe critical events in children undergoing anaesthesia in Europe.

The study aims to include all children from birth to 15 years old scheduled for an elective or urgent diagnostic or surgical procedure under sedation or general anaesthesia with or without regional analgesia or under regional anaesthesia. This represents the denominator dataset for calculation of the incidence of severe critical events, which is the primary aim of the study. The anaesthesiologist in charge will record the occurrence of selected severe critical events during and up to 60 minutes after anaesthesia or sedation AND requiring immediate intervention. These severe critical incidents include: Laryngospasm, Bronchospasm, Pulmonary aspiration, Drug error, Anaphylaxis, Cardiovascular instability, Neurological damage, Perianaesthetic cardiac arrest and postanaesthetic Stridor. The secondary endpoint is represented by the risk factors and the consequences for the occurrence of these severe critical events including in-hospital mortality established up to 30 days or at discharge. Relevant aspects of the child's medical and family history will be recorded.

Following sample size estimation, we plan to recruit at least 25 000 children over a period of two consecutive weeks including weekends and after-hours across the 30 European countries represented at the European Society of Anaesthesiology Council or part of geographical Europe. The 2-week recruitment period will be chosen by each site commencing on 15 March 2014.The last possible inclusion date will be decided by the Study Steering Committee depending on the recruitment rate. Participating hospitals will be provided with data acquisition sheets that enable anonymous standardized recording of all patients' parameters, which will be used by the local institution to fill in the electronic case report form (eCRF).

Descriptive statistical analysis will be performed for the primary endpoint (occurrence of severe critical events and 95% confidence interval). Univariate and multivariate analysis will be performed to test factors associated with the endpoint. Results of logistic regression will be reported as adjusted odds ratio (OR) with 95 % confidence intervals.


Layout table for study information
Study Type : Observational
Actual Enrollment : 30000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: APRICOT: Anaesthesia PRactice In Children Observational Trial - European Prospective Multicenter Observational Study: Epidemiology of Severe Critical Events in Paediatric Anaesthesia
Study Start Date : March 2014
Actual Primary Completion Date : January 2015
Actual Study Completion Date : April 2015



Primary Outcome Measures :
  1. Incidence of severe critical events [ Time Frame: Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards ]

    Incidence of the following severe critical events defined as any incident occurring during and up to 60 minutes after anaesthesia or sedation (PACU), requiring immediate intervention and that may lead to major disability and/or death:

    • Laryngospasm
    • Bronchospasm
    • Pulmonary aspiration
    • Drug error
    • Anaphylaxis
    • Cardiovascular instability
    • Neurological damage
    • Perianaesthetic Cardiac arrest
    • Postanaesthetic Stridor (in the PACU)


Secondary Outcome Measures :
  1. Risk factors for the occurrence of severe critical events [ Time Frame: Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards ]
    Assessment of risk factors will be achieved by collecting data on social and demographic data of the patients, family and child's medical history, presence of co-morbidities, details on anesthesia procedure, elective or emergency cases, level of experience of the anesthesiologist, postoperative prescriptions.

  2. Consequences of the critical events: irreversible damage, in-hospital mortality [ Time Frame: in-hospital and up to 30 days ]
    Consequences of critical events: no harm, minor sequelae, irreversible damage, in-hospital mortality (up to 30 days or discharge).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Children from birth to 15 years included admitted for an inpatient or outpatient procedure under general anaesthesia with or without regional analgesia or admitted for a diagnostic procedure under general anaesthesia (such as endoscopy, radiology…) or admitted out-of-hours for emergency procedures
Criteria

Inclusion Criteria:

  • Age: from birth to 15 years included
  • All children admitted for an inpatient or outpatient procedure under general anaesthesia with or without regional analgesia or under regional anaesthesia alone. This includes all kind of surgeries and procedures requiring anaesthesia and analgesia to be performed such as central venous access, burn care, cast, etc.,
  • Children admitted for a diagnostic procedure under sedation (performed by an Anaesthetist) or general anaesthesia (such as endoscopy, radiology (CT-scan, MRI), cardiac catheterisation and electrophysiology, PET-scan, radiotherapy, lumbar and bone marrow puncture, biopsies), diagnostic procedure under general anaesthesia (such as endoscopy, radiology…)
  • Children admitted for urgent or emergency procedure performed in- or out-of-hours.

Exclusion Criteria:

  • Children admitted directly from the intensive care units to the operating rooms
  • Anaesthesia procedures in the neonatal or paediatric intensive care units.
  • Age: All children aged ≥ 16 years.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01878760


  Show 38 Study Locations
Sponsors and Collaborators
European Society of Anaesthesiology
Investigators
Layout table for investigator information
Study Chair: Walid Habre, M.D. University Hospital, Geneva
Study Director: Francis Veyckemans, M.D. Cliniques Universitaires St Luc asbl Brussels

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: European Society of Anaesthesiology
ClinicalTrials.gov Identifier: NCT01878760     History of Changes
Other Study ID Numbers: APRICOT
First Posted: June 17, 2013    Key Record Dates
Last Update Posted: October 14, 2015
Last Verified: October 2015
Keywords provided by European Society of Anaesthesiology:
APRICOT
Anaesthesia
Children
kids
Paediatric Anaesthesia
Observational Trial
epidemiology
severe critical events in
European Society of Anaesthesiology
Europe
Additional relevant MeSH terms:
Layout table for MeSH terms
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs